Rosemarie Einstein

676 total citations
41 papers, 519 citations indexed

About

Rosemarie Einstein is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Rosemarie Einstein has authored 41 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Cardiology and Cardiovascular Medicine and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Rosemarie Einstein's work include Receptor Mechanisms and Signaling (11 papers), Veterinary Pharmacology and Anesthesia (7 papers) and Neuroendocrine regulation and behavior (6 papers). Rosemarie Einstein is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Veterinary Pharmacology and Anesthesia (7 papers) and Neuroendocrine regulation and behavior (6 papers). Rosemarie Einstein collaborates with scholars based in Australia, United Kingdom and United States. Rosemarie Einstein's co-authors include L. B. Cobbin, M. Helen Maguire, N. A. Lavidis, Dennis Chang, A. H. Goodman, Colin Wheeler, Cristobal G. dos Remedios, Michael J. Dünn, James A. Angus and Jun X. Yan and has published in prestigious journals such as Circulation Research, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Rosemarie Einstein

41 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosemarie Einstein Australia 14 192 146 85 60 58 41 519
Daniel Beacham United States 10 306 1.6× 78 0.5× 224 2.6× 12 0.2× 18 0.3× 13 576
Maria R. Depaoli Austria 11 251 1.3× 38 0.3× 71 0.8× 25 0.4× 20 0.3× 14 735
Heather Prince United Kingdom 7 416 2.2× 37 0.3× 546 6.4× 25 0.4× 8 0.1× 11 856
J F Fiekers United States 14 388 2.0× 94 0.6× 237 2.8× 8 0.1× 13 0.2× 30 629
Agnès Choppin United States 14 434 2.3× 49 0.3× 294 3.5× 16 0.3× 13 0.2× 26 830
R. Levine United States 14 222 1.2× 196 1.3× 150 1.8× 5 0.1× 11 0.2× 22 718
Béatrice Georges France 14 243 1.3× 19 0.1× 83 1.0× 8 0.1× 10 0.2× 26 711
Erik Klinge Finland 17 151 0.8× 56 0.4× 306 3.6× 7 0.1× 9 0.2× 55 859
Shanti Diwakarla Australia 18 262 1.4× 79 0.5× 225 2.6× 6 0.1× 14 0.2× 36 690
Meiyan Jiang China 12 172 0.9× 53 0.4× 35 0.4× 7 0.1× 23 0.4× 23 670

Countries citing papers authored by Rosemarie Einstein

Since Specialization
Citations

This map shows the geographic impact of Rosemarie Einstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemarie Einstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemarie Einstein more than expected).

Fields of papers citing papers by Rosemarie Einstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemarie Einstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemarie Einstein. The network helps show where Rosemarie Einstein may publish in the future.

Co-authorship network of co-authors of Rosemarie Einstein

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemarie Einstein. A scholar is included among the top collaborators of Rosemarie Einstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemarie Einstein. Rosemarie Einstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Einstein, Rosemarie, et al.. (2001). Effects of restraint stress on responsiveness of atria and vas deferens in Sprague–Dawley rats. Journal of Autonomic Pharmacology. 21(5). 255–261. 5 indexed citations
2.
Bendall, Jason, et al.. (2001). Sodium bicarbonate improves the chance of resuscitation after 10 minutes of cardiac arrest in dogs. Resuscitation. 51(3). 309–315. 24 indexed citations
3.
Einstein, Rosemarie, et al.. (1999). Stress induced changes in transmitter release from sympathetic varicosities of the mouse vas deferens. Journal of the Autonomic Nervous System. 76(2-3). 146–152. 6 indexed citations
4.
Wheeler, Colin, Jun X. Yan, Vaksha Amin, et al.. (1999). Changes in myocardial protein expression in pacing-induced canine heart failure. Electrophoresis. 20(10). 2086–2093. 69 indexed citations
5.
Wheeler, Colin, et al.. (1998). Protein changes observed in pacing‐induced heart failure using two‐dimensional electrophoresis. Electrophoresis. 19(11). 2021–2030. 65 indexed citations
6.
Einstein, Rosemarie, et al.. (1998). Ventricular fibrillation and defibrillation thresholds in sheep and dogs. Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 121(1). 77–82. 3 indexed citations
7.
8.
Einstein, Rosemarie, et al.. (1995). Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, 1994: ANIMAL MODELS OF HEART FAILURE FOR PHARMACOLOGICAL STUDIES. Clinical and Experimental Pharmacology and Physiology. 22(11). 864–868. 7 indexed citations
9.
Einstein, Rosemarie, et al.. (1995). ‘Atypical’ Tremor. European Neurology. 35(6). 321–326. 13 indexed citations
10.
Weiss, Steven M., et al.. (1991). Can Changes in Transcardiac Impedance Appropriately Detect Ventricular Fibrillation?. Pacing and Clinical Electrophysiology. 14(2). 352–357. 1 indexed citations
11.
Einstein, Rosemarie, et al.. (1991). The effects of neuropeptide Y on myocardial contractility and coronary blood flow. British Journal of Pharmacology. 104(1). 195–201. 17 indexed citations
12.
Einstein, Rosemarie, et al.. (1988). Inotropic activity of digitoxigenin glucoside and related glycosides.. PubMed. 38(8). 1115–9. 1 indexed citations
13.
Einstein, Rosemarie, et al.. (1987). Positive inotropic effects of histamine in anaesthetized dogs. British Journal of Pharmacology. 92(2). 445–450. 6 indexed citations
14.
Einstein, Rosemarie & N. A. Lavidis. (1984). The dependence of excitatory junction potential amplitude on the external calcium concentration in narcotic tolerant mouse vas deferens. British Journal of Pharmacology. 83(4). 853–861. 11 indexed citations
15.
Einstein, Rosemarie, et al.. (1983). Chronic haloperidol and adrenergic receptor sensitivity in the rat. Journal of Neural Transmission. 57(1-2). 13–25. 2 indexed citations
16.
Einstein, Rosemarie, et al.. (1983). Relative inotropic and chronotropic activity of β-adrenoceptor stimulants in anaesthetised, areflexic dogs. European Journal of Pharmacology. 86(3-4). 461–466. 2 indexed citations
17.
Goodman, A. H., Rosemarie Einstein, & Harris J. Granger. (1978). Effect of changing metabolic rate on local blood flow control in the canine hindlimb.. Circulation Research. 43(5). 769–776. 23 indexed citations
18.
Hindmarch, I., Ian Hughes, & Rosemarie Einstein. (1975). Attitudes to drug users and to the use of alcohol, tobacco and cannabis on the campus of a provincial university.. PubMed. 27(1). 27–36. 1 indexed citations
19.
Einstein, Rosemarie, I E Hughes, & I. Hindmarch. (1975). Patterns of Use of Alcohol, Cannabis and Tobacco in a Student Population. British Journal of Addiction to Alcohol & Other Drugs. 70(2). 145–150. 6 indexed citations
20.
Angus, James A., L. B. Cobbin, Rosemarie Einstein, & M. Helen Maguire. (1971). Cardiovascular actions of substituted adenosine analogues. British Journal of Pharmacology. 41(4). 592–599. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Beacham Breakdown of academic impact, for papers by Maria R. Depaoli Breakdown of academic impact, for papers by Heather Prince Breakdown of academic impact, for papers by J F Fiekers Breakdown of academic impact, for papers by Agnès Choppin Breakdown of academic impact, for papers by R. Levine Breakdown of academic impact, for papers by Béatrice Georges Breakdown of academic impact, for papers by Erik Klinge Breakdown of academic impact, for papers by Shanti Diwakarla Breakdown of academic impact, for papers by Meiyan Jiang
Rankless by CCL
2026